DODGE & COXDODGE & COX

Institutional investor · Portfolio as of Q3 2025

Top Holdings219 positions

Checking export access…
Activity:

Charles Schwab Corp/The

83M$7.9B4.3%$43.19+118.27%
28 qtrssince 2018-Q4
Decreased
0

JOHNSON CONTROLS INTERNATION

64.2M$7.1B3.8%$36.44+199.15%
28 qtrssince 2018-Q4
Decreased
0

RTX CORPORATION

40.1M$6.7B3.6%$62.48+163.89%
22 qtrssince 2020-Q2
Decreased
0

CVS Health Corp

73.2M$5.5B3.0%$57.68+26.69%
28 qtrssince 2018-Q4
Decreased
0

Fiserv Inc

38.6M$5B2.7%$114.12+12.97%
20 qtrssince 2020-Q4
Increased
69

METLIFE INC

53.7M$4.4B2.4%$32.94+143.11%
28 qtrssince 2018-Q4
Increased
55

Microsoft Corp.

7.9M$4.1B2.2%$125.17+310.41%
28 qtrssince 2018-Q4
Decreased
0

FedEx Corp

16.2M$3.8B2.1%$142.98+30.68%
28 qtrssince 2018-Q4
Increased
61

BANK OF NY MELLON CORP

34.8M$3.8B2.0%$36.29+195.07%
28 qtrssince 2018-Q4
Decreased
0

OCCIDENTAL PETE CORP

79.9M$3.8B2.0%$37.00+25.21%
28 qtrssince 2018-Q4
Decreased
0

Booking Holdings Inc

675,082$3.6B2.0%$66.92+219.81%
28 qtrssince 2018-Q4
Decreased
0

Amazon.com Inc

16.3M$3.6B1.9%$102.67+113.86%
28 qtrssince 2018-Q4
Decreased
0

COMCAST CORP NEW

112.6M$3.5B1.9%$28.37-2.51%
28 qtrssince 2018-Q4
Increased
51

TE Connectivity PLC

16M$3.5B1.9%$148.06+46.68%
5 qtrssince 2024-Q3
Decreased
0

Alphabet Inc CL C

14M$3.4B1.8%$54.91+342.36%
28 qtrssince 2018-Q4
Decreased
0
GSKGSK
ADR

GSK PLC

78.4M$3.4B1.8%$27.45+51.83%
13 qtrssince 2022-Q3
Decreased
0

Gilead Sciences Inc

30.1M$3.3B1.8%$52.66+105.72%
28 qtrssince 2018-Q4
Decreased
0

UnitedHealth Group Inc

9.5M$3.3B1.8%$289.38+16.23%
28 qtrssince 2018-Q4
Increased
55

NORFOLK SOUTHN CORP

10.9M$3.3B1.8%$207.89+42.00%
28 qtrssince 2018-Q4
Increased
50

WELLS FARGO & CO

38.9M$3.3B1.8%$31.25+162.48%
28 qtrssince 2018-Q4
Decreased
0
$185.3B
AUM
219
Positions
Q3 2025
Filing
HI score · 3.0/5
Quarterly 13F Value Change
-3%Q2'24$166.6B+6%Q3'24$176.8B-3%Q4'24$171.8B+2%Q1'25$175.5B+1%Q2'25$178B+4%Q3'25$185.3B
Activity profile
$ moved · Q3'25
New5%Increased45%Decreased47%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.9 years
<1Q2%1-4Q9%1-2Y10%2Y+79%

DODGE & COX manages $185.3B across 219 positions as of Q3 2025. Top holdings: SCHW (4.3%), JCI (3.8%), RTX (3.6%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3/5.0.

Q3 2025 Summary

Active quarter - 6 new positions, 6 exits, 50 increased. Top move: FISV (INCREASED, conviction 69). Portfolio: $185.3B across 219 positions.

Top holdings by portfolio weight

Total AUM$185B
SCHW4.28%
JCI3.81%
RTX3.62%
CVS2.98%
FISV2.69%
MET2.38%
MSFT2.20%
FDX2.06%
BK2.05%
OXY2.04%
Other1.97%

Portfolio allocation by GICS sector

Sectors11
Healthcare23.72%
Financial Services18.28%
Industrials12.84%
Communication Services11.31%
Technology9.31%
Consumer Cyclical6.80%
Energy4.71%
Basic Materials4.50%
Unknown2.69%
Real Estate2.36%
Other3.48%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Financial Services, Industrials
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L76
Conviction37
Concentration42
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
CMCSACMCSACOMCAST CORP NEW
Q4 2024 → Q2 2026+41.8M shares-$248.2M
7Q
CPNGCPNGCOUPANG INC
Q4 2024 → Q2 2026+52.1M shares+$760.4M
7Q
LPLALPLALPL FINL HLDGS INC
Q4 2024 → Q2 2026+4.6M shares+$1.3B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used